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Available online 17 April 2012Abstract Themain physiological function of adipose-derived stromal/progenitor cells (ASC) is to differentiate into adipocytes. ASC
are most likely localized at perivascular sites in adipose tissues and retain the capacity to differentiate into multiple cell types.
Although cell surfacemarkers for ASC have been described, there is no complete consensus on the antigen expression pattern that will
precisely define these cells. DLK1(PREF1) is an established marker for mouse adipocyte progenitors which inhibits adipogenesis. This
suggests that DLK1(PREF1) could be a useful marker to characterize human ASC. The DLK1(PREF1) status of human ASC is however
unknown. In the present study we isolated ASC from the heterogeneous stromal vascular fraction of subcutaneous abdominal fat pats
of adult women. These cells were selected by their plastic adherence and expanded to passage 5. The ASC were characterized as
relatively homogenous cell population with the capacity to differentiate in vitro into adipocytes, chondrocytes, and osteoblasts and
the immunophenotype CD105+/CD90+/CD34+/CD31−/FABP4−. The ASC were positive for DLK1(PREF1) which was well expressed in
proliferating and density arrested cells but downregulated in the course of adipogenic differentiation. To investigate whether
DLK1(PREF1) plays a role in the regulation of adipogenesis in these cells RNAi-mediated knockdown experiments were conducted.
Knockdown of DLK1(PREF1) in differentiating ASC resulted in a significant increase of the expression of the adipogenic key regulator
PPARγ2 and of the terminal adipogenic differentiation marker FABP4. We conclude that DLK1(PREF1) is well expressed in human ASC
and acts as a negative regulator of adipogenesis. Moreover, DLK1(PREF1) could be a functional marker contributing to the
characterization of human ASC.
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White adipose tissues are the primary triglyceride/energy
storages of the body acting as metabolic regulator in glucose
homeostasis and lipid metabolism (Rosen and Spiegelman,
2006), and as endocrine organ (Hauner, 2005). The main cell
type in fat tissues fulfilling these functions is the mature
adipocyte. In adult humans approximately 10% of fat cells in
adipose depots are renewed annually (Spalding et al., 2008),
and surgical removal of fat tissue in rodents induces
compensatory recovery (Mauer et al., 2001). This indicates
a high demand of progenitor cells for renewal and, hence,
maintenance of adipose tissue functions. In fact, the number
of adipocyte progenitors in a given fat tissue can vary
between 15 and 40% of the cell population dependent on the
tissue type, localization in the body, physiological con-
ditions, and age (Bouloumie et al., 2008; Cartwright et al.,
2010; Hauner, 2005).
White adipocyte progenitor cells were identified in vivo
(Rodeheffer et al., 2008), and evidence provided by several
studies indicates that these cells are responsible for regenerat-
ing adipocyte numbers in fat tissues (Bertrand et al., 1978;
Gesta et al., 2007; Hauner et al., 1989; Hausman and Hausman,
2006; Rodeheffer et al., 2008; Zuk et al., 2002). In addition to
adipocyte hypertrophy, an increased proliferation and adipo-
genic differentiation of ASC contributes to the adipose tissue
growth that is characteristic for obesity (Drolet et al., 2008;
Gesta et al., 2007; Tchoukalova et al., 2010). ASC reside most
likely mainly at perivascular sites in adipose tissues (Crossno et
al., 2006; Tang et al., 2008; Zimmerlin et al., 2010). The
number of intermediate stages between adipose progenitors
and a mature adipocytes is uncertain but once committed, ASC
can enter an adipocyte differentiation program (adipogenesis)
to acquire their specific functions as adipocytes (Cristancho and
Lazar, 2011; Farmer, 2006; Rosen and MacDougald, 2006).
Adipogenesis in human ASC involves growth arrest, early and
terminal differentiation, including morphological changes,
lipid accumulation and the expression of fat cell specific
genes, for example fatty acid binding protein-4 (FABP4) and
adipokines, such as leptin and adiponectin. The stages of
adipocyte differentiation are orchestrated by a transcriptional
cascade involving adipogenic key factors, such as the nuclear
receptor peroxisome proliferator-activated receptor-γ2
(PPARγ2) and members of the CCAAT/enhancer-binding
protein (C/EBP) family (Farmer, 2006; Rosen and
MacDougald, 2006).
Adipose-derived stromal cells (ASC) are most frequently
isolated by collagenase digestion of white adipose tissue,
yielding a stromal vascular fraction (SVF) which contains a
mixture of heterogeneous cell types that are further purified
by differential centrifugation, plating and plastic adherence
(Hauner et al., 1989; Mitchell et al., 2006; Zuk et al., 2002).
It has been shown that a single adherent cell derived from the
SVF can be expanded generating a daughter cell population
with multipotent differentiation capacity, defined as an
adult stem cell (Guilak et al., 2006; Mitchell et al., 2006). As
ASC possess no unique morphological characteristics great
efforts are made to characterize this cell type by specific
marker proteins. Although in many studies specific pattern of
cellular surface markers were assigned to human ASC com-
prising the combination CD90+/CD105+/CD34+/CD31− (Gimble
et al., 2011; Maumus et al., 2008; McIntosh et al., 2006;Mitchell et al., 2006; Schaffler and Buchler, 2007; Sengenes et
al., 2005, 2007; Zimmerlin et al., 2010), there is no complete
consensus on the antigen expression pattern thatwill precisely
define human ASC. Moreover, evidence was presented that
the immunophenotype of ASC can change during expansion in
cell culture, likely influenced by adherence to plastic culture
dishes, and proliferation in medium with high concentrations
of fetal bovine serum (FBS), that contains variable and un-
defined factors influencing proliferation, differentiation and
survival of adult stem cells (McIntosh et al., 2006; Mitchell et
al., 2006; Parker et al., 2007).
Delta-like protein 1/preadipocyte factor-1 (DLK1/PREF1),
which was originally identified as an inhibitor of adipogenesis
in the murine preadipocyte cell line NIH 3T3-L1 (Smas and Sul,
1993), is used as preadipocyte marker (Rodeheffer et al.,
2008; Smas and Sul, 1993; Tang et al., 2008; Tseng et al.,
2005; Wang et al., 2008). Similar to Notch, DLK1(PREF1) is an
epidermal growth factor repeat containing transmembrane
protein that is proteolytically converted at the extracellular
domain to generate a physiologically active soluble form that
inhibits adipocyte differentiation (Sul, 2009). Adipocyte
progenitors are the sole cell type expressing DLK1(PREF1) in
mouse adipose tissues. DLK1(PREF1) knockout mice show
accelerated fat deposition, whereas mice overexpressing
DLK1(PREF1) in adipose tissue exhibit decreased fat mass
(Gesta et al., 2007; Lee et al., 2003; Moon et al., 2002; Sul,
2009; Villena et al., 2008). DLK1(PREF1) was shown to play a
role in the regulation of cell commitment and differentiation
in murine multipotent mesenchymal cells regulating fat mass
and bonemass formation in vivo (Abdallah et al., 2007a, 2011;
Moon et al., 2002; Villena et al., 2008; Wang and Sul, 2009).
DLK1(PREF1) can also stimulate bone resorption in mice
(Abdallah et al., 2011). DLK1(PREF1) suppresses C/EBPβ and
C/EBPδ gene expression in mouse preadipocytes which leads
to prevention of adipogenesis (Wang and Sul, 2009). Moreover,
DLK1(PREF1) can direct murine multipotent mesenchymal
cells to the chondrogenic lineage but it inhibits differentiation
into osteoblasts as well as chondrocytes (Chen et al., 2011;
Harkness et al., 2009; Wang and Sul, 2009). DLK1(PREF1) was
also shown to be expressed in human bone marrow-derived
(BM) mesenchymal stem cells (MSC), but at relatively low
levels (Abdallah et al., 2004, 2007b, 2011; Jing et al., 2009). It
keeps these cells in an undifferentiated state and regulates
their differentiation into osteoblasts or adipocytes, at least in
part by influencing their microenvironment composition
(Abdallah et al., 2007a, 2007b, 2011; Jing et al., 2009). Low
expression of DLK1(PREF1) was also found in human cord blood
(CB) MSC correlating with a strong adipogenic differentiation
potential (Kluth et al., 2010). Moreover, DLK1(PREF1) over-
expression inhibits adipogenesis as well as osteogenesis in CB
MSC (Kluth et al., 2010). Together these data suggest that
DLK1(PREF1) is an important regulator of mesenchymal stem
cell differentiation. Thus DLK1(PREF1) could be a useful
marker to characterize human ASC, however, the
DLK1(PREF1) status of these cells is unknown.
In the present study, we isolated defined populations of
ASC from human abdominal subcutaneous fat tissue derived
from 4 different women. The immunophenotype and the in
vitro differentiation capacity of these cells were analyzed
after expansion in medium with low concentrations of FBS
until passage 5. Moreover, the significance of DLK1(PREF1)
for adipogenic differentiation of these cells was studied.
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Immunophenotype of human ASC derived from
abdominal subcutaneous fat pads
Fresh human abdominal subcutaneous fat pads obtained by
surgical resection were processed for the isolation of the
stromal-vascular cell fraction (SVF) (Supplemental Fig. 1A),
essentially as described (Hauner et al., 1989; McIntosh et al.,
2006; Rodriguez et al., 2004). The heterogeneous SVF was
maintained in ASC medium with 10% FBS for 16 h to allow cell
attachment on plastic cell culture dishes (passage −1, P-1).
Subsequently the cells were kept in serum-free ASC medium
for 6 days. Contaminating non adherent cells were removed by
changing the medium. The resulting cell fraction was referred
to as ASC passage 0 (P0). Under these conditions 230,000±
100,000 SVF cells were isolated per gram fat tissue and
19%±6%were recovered from the SVF as adherent ASC at P0. It
should be considered that the cell yield per mg fat depends on
the donor tissue. The ASC were expanded until passage 5 in
PM4 medium (Skurk et al., 2007) containing low concentra-
tions of insulin, EGF, FGF and 2.5% FBS in a 20% O2/5% CO2
atmosphere. Under these conditions the ASC proliferated
robustly with a doubling time of ~60 h. To identify potential
heterogeneous cells, the adherent cell fraction was stained
with antibodies against fibroblast specific protein 1 (FSP1), F4/
80(EMR1), a macrophage marker, and von Willebrand factor
(VWF), an endothelial cell specific protein (Supplemental Fig.
1B). The analysis of 10,000 cells for each marker by indirect
immunofluorescence analysis viewed through a confocal laser-
scanning microscope demonstrated that the vast majority of
the ASC culture was free of fibroblasts, macrophages and
endothelial cells. To underline these results qRT-PCR was
performed to show the mRNA expression of FSP1, F4/80, and
VWF. F4/80 mRNA was not detectable in ASC compared to
PBMC andmonocytes (Supplemental Fig. 1C, upper panel). This
was also found for VWF mRNA compared with HUVEC
(Supplemental Fig. 1C, middle panel). FSP1 mRNA was also
relatively low in ASC relative to human foreskin fibroblasts
(Supplemental Fig. 1C, lower panel). These data indicate that
after isolation from the adipose SVF, 6 days FBS starvation
on plastic cell culture dishes, and expansion until passage 5
in PM4medium, we obtained a homogeneous cell population
concerning the examined markers, although it is likely that
there are other markers that are not homogeneously
expressed. This cell population was referred to as the
adipose-derived stromal cell (ASC) fraction which was used
for further studies. This cell population contains an
enriched population of adipose stem/progenitor cells but
most likely not all of the cells are stem cells, as defined by
rigorous criteria.
The population of ASC was further characterized in indirect
immunofluorescence experiments by antibodies against estab-
lished marker proteins used as major lineage determinant
proteins (Supplemental Fig. 1D). CD90 (Thy1) and CD105
(endoglin) are known as mesenchymal stem cell (MSC) markers
(Gimble and Guilak, 2003) which are also expressed in HUVEC
cells (Magin et al., 2009) (Supplemental Fig. 1D). CD34 is not
expressed on MSC (Pittenger et al., 1999), but in both
hematopoietic (Civin et al., 1984) and endothelial (Asahara
et al., 1997) progenitors (Supplemental Fig. 1D). CD31
(PECAM-1) is a marker for endothelial cells (Gimble andGuilak, 2003; Invernici et al., 2005) (Supplemental Fig. 1D).
Our ASC highly expressed CD90, CD105 and CD34 but not CD31
(Fig. 1A), as shown previously (Sengenes et al., 2007).We found
that a considerable proportion of CD105 was not localized on
the cell surface but in intracellular structures. To identify these
structures we co-stained the ASC with antibodies against CD105
in combination with antibodies against either calnexin, a
protein of the endoplasmatic reticulum (ER), or GM130, a
protein of the Golgi apparatus. Confocal microscopy analysis
demonstrated that considerable proportions of CD105 co-
localized with structures of the Golgi apparatus as well as the
ER (Fig. 1B). DLK1(PREF1) is an established marker for mouse
adipocyte progenitors (Sul, 2009). The DLK1(PREF1) status of
human ASC is unknown. Indirect immunofluorescence exper-
iments demonstrated that all cells in the ASC population at
passage 5 stained strongly positive for DLK1(PREF1) (Fig. 1A).
As indicated by their specific marker composition, the ASC
vary significantly from MSC, HSC, HUVEC, macrophages and
fibroblasts. The immunofluorescence microscopy analysis of
10,000 cells for each marker indicated a homogeneity of the
DLK1(PREF1)+/CD105+/CD90+/CD34+/CD31− ASC fraction of
≥99.8%. To corroborate these data and to demonstrate the
presence of DLK1(PREF1), CD105, CD90, and CD34 and the
absence of CD31 in the same cell, passage 5 ASC were
subjected to multi-parameter detection FACS analysis. We
found that the vast majority of the cells was in fact
DLK1(PREF1)+/CD105+/CD90+/CD34+/CD31− (Fig. 1C).
Since DLK1(PREF1) was identified as a novel marker protein
for human ASC it was interesting to monitor the purification of
DLK1(PREF1) positive cells during enrichment of the ASC from
the SVF and sub cultivation to passage 6 by FACS analysis
(Fig. 1D, upper panel). In the SVF we detected 41.1 (±3.6) %
DLK1(PREF1) positive cells. After attachment of the ASC on
plastic cell culture dishes (passage −1) 82.3 (±1.6) % of the cell
population stained positive for DLK1(PREF1). At passage 0, we
measured 98.5 (±0.3) % DLK1(PREF1) positive cells and at
passage 1, 99.1 (±0.2) % of the cells were DLK1(PREF1) positive.
At passages 4 and 6 the number of DLK1(PREF1) positive cells
was 100%. The enrichment of DLK1(PREF1) expressing cells was
also monitored by indirect immunofluorescence microscopy
analysis (Fig. 1D, lower panel). Similar to the results of the
FACS analysis we counted ~43% DLK1(PREF1) positive cells in
the SVF; ~ 82% in passage −1, ~98% in passage 0 and ~99% in
passage 1. Thus almost all passage 0 cells of the human ASC
populationwere positive for DLK1(PREF1) and the expression of
this protein remained high at later passages. To follow up the
enrichment of the ASC population from the SVF we also
analyzed the expression of lineage determinant genes by qRT-
PCR in the cell mixture of the SVF and the isolated ASC. We
found a 2.5 fold increase in the CD90 expression (Fig. 1E),
suggesting that CD90+ stem cells are enriched. In contrary,
CD31 mRNA expression was 3 times reduced in the ASC pop-
ulation (Fig. 1E), most likely reflecting the removal of floating
endothelial cells.
To determine the amount of adipocyte committed and/or
differentiated cells in the ASC fraction the expression levels
of the adipogenic differentiation marker FABP4 were mea-
sured (Fig. 1F). FABP4 mRNA was not detectable in the ASC
fraction, suggesting that adipocytes were removed during
purification. In summary, the isolated ASC were character-
ized as DLK1(PREF1)+/CD105+/CD90+/CD34+/CD31−/FABP4−
cells. We obtained similar results with ASC populations
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and 47 years.DLK1(PREF1)+/CD105+/CD90+/CD34+/CD31−/FABP4−
human ASC possess multipotent differentiation
capacity in in vitro assays
Tissue-specific stem cells possess the capability to differenti-
ate into various lineages (Gimble and Guilak, 2003; Pittengeret al., 1999; Rodriguez et al., 2004; Rossi and Sharpless, 2008;
Zuk et al., 2002). To get a better insight into the potential of
the ASC population to differentiate into adipocytes, adipogen-
esis was induced with a hormone cocktail containing dexa-
methasone, IBMX, insulin and 2.5% FBS (DMI) (Fig. 2A).
Confocal immunofluorescence microscopy analysis demonstrat-
ed that the ASC marker DLK1(PREF1) was highly expressed in
proliferating (Fig. 2A, top panel) and to a similar extent in
density-arrested ASC, which stay in the G0/G1 phase of the cell
cycle at day 0 of differentiation (Fig. 2A, middle left panel).
39DLK1(PREF1) negatively regulates adipogenesis in CD105+/CD90+/CD34+/CD31− adipose progenitorsAfter 14 days of differentiation the DLK1(PREF1) protein was
almost undetectable (Fig. 2A, bottom left panel). In contrast,
the adipogenic differentiation marker FABP4 was not detect-
able at day 0 but strongly induced at day 14 of differentiation
(Fig. 2A, right panel). The strong reduction of DLK1(PREF1) and
induction of FABP4 during differentiation was corroborated at
the mRNA level by qRT-PCR (Fig. 2B) and by western blot
analysis (Fig. 2C). qRT-PCR analysis also demonstrated that the
expression of the adipogenic key transcription factors PPARγ2
(Fig. 2D) and C/EBPα (Fig. 2E) was strongly induced during
adipogenesis. Moreover, two terminal adipogenic differentia-
tion markers, the adipokines adiponectin and leptin, were well
induced in the ASC at day 9 of differentiation (Fig. 2F and G). To
finally assess the ability of the ASC to differentiate in in vitro
assays into other mesenchymal lineages, ASC were put under
chondrogenic, osteogenic and adipogenic differentiation con-
ditions (Fig. 2H). As expected, based on their tissue of origin,
the ASC underwent strong adipogenic differentiation, shown by
Oil RedO staining of the formed lipid droplets. We detected
differences in the strength of the in vitro adipogenicmaturation
of single ASC isolated from the same depot, as reflected by the
difference in the quantity and size of lipid droplets (Fig. 2H,
compare white and yellow arrows). Staining of the glycosami-
noglycans in chondrocytes with Alcian Blue and of the osteocyte
specific calcification with Alizarin Red S demonstrated that the
ASC could differentiate in all three mesenchymal cell types in
vitro. Although these findings warrant further studies, employ-
ing a chondrogenic assay in a pellet culture and an osteogenic
assay best done by in vivo transplantation, they suggest that
clones isolated from our purified cell population most likely
fulfil the criteria of adult tissue-specific multipotent stem cells
(Gimble and Guilak, 2003; Pittenger et al., 1999; Rodriguez et
al., 2004; Rossi and Sharpless, 2008; Zuk et al., 2002).Figure 1 Characterization of human adipose-derived stromal cells
CD34+/CD31− cells. Immunofluorescence staining of freshly isolated A
primary antibodies against DLK1(PREF1), CD105, CD90, CD34, CD31, a
for immunofluorescence microscopy using a confocal laser scanning
400×). (B) Co-localization of CD105 with calnexin (ER protein) and
staining of freshly isolated ASC (passage 5) is shown. Cells were fix
calnexin, and GM130 and Alexa Fluor 488 nm-conjugated (green) o
indicated. Nuclei were stained with TO-PRO-3 (red). Merge (yellow
immunofluorescence microscopy using a confocal laser scanning syste
FACS analysis. 50,000 cells were counted using a BD FACS CantoII™ fl
stained for CD105, CD90, CD34, CD31, and DLK1(PREF1) are shown.
analyses. Red histograms: unstained control; blue histograms: anti
during purification of ASC from the SVF and sub cultivation until p
passage P-1, P0, P1, P4 and P6) were analyzed for DLK1(PREF1) stain
DLK1(PREF1) positive cells in each fraction is shown. Three independ
(Lower panel) Immunofluorescence staining of DLK1(PREF1) positive
PFA, stained with a primary antibody against DLK1(PREF1) and FITC
with TO-PRO-3 (red). Cells were viewed by immunofluorescence mi
400×). For the determination of the percentage of DLK1(PREF1) pos
mRNA expression in ASC. RNA samples of SVF and ASC cells were i
against CD90 and CD31. Expression results were normalized to TAT
values which were set to 1. The induction was calculated based on SV
(F) FABP4 mRNA expression in ASC. RNA samples of SVF and ASC ce
primers against FABP4. Expression results were normalized to TATA
values which were set to 1. The induction was calculated based on SVDLK1(PREF1) negatively regulates adipogenesis in
human ASC
To better understand the function of DLK1(PREF1) in human
ASC biology, we studied the effect of DLK1(PREF1) shRNA
knockdown on the adipogenic differentiation potential of ASC.
DLK1(PREF1) was knocked down using two different shRNA
constructs for DLK1(PREF1) mRNA, sh#2 and sh#3 (Fig. 3). A
strong reduction of DLK1(PREF1) mRNA was found in sh#2- and
sh#3-containing ASC (Fig. 3A) and DLK1(PREF1) protein was
significantly reduced by both sh#2 and sh#3 (Fig. 3B). ASC
infected with a DLK1(PREF1) overexpressing lentivirus, pLen-
tiDLK1(PREF1), served as positive control (Fig. 3B). The
effects of the DLK1(PREF1) knockdown on the induction and
progression of adipogenesis were monitored by assessing the
expression of the key adipogenic regulator PPARγ2 and of the
terminal adipogenic differentiation product FABP4. We found
a significant increase in the induction of PPARγ2 and FABP4
expression in the DLK1(PREF1) knockdown cells at day 3 of
adipogenesis compared to the control cells (Fig. 3C). We
conclude that the knockdown of DLK1(PREF1) enhances
adipogenic differentiation in human ASC.Discussion
In the present study we isolated ASC populations from
subcutaneous abdominal fat pats of different donors and
characterized these cells by their plastic adherent proper-
ties, their immunophenotype, DLK1(PREF1)+/CD105+/CD90+/
CD34+/CD31−/FABP4−, and a multipotent in vitro differentia-
tion potential. Moreover, we demonstrated that DLK1(PREF1)(ASC). (A) Identification of ASC as DLK1(PREF1)+/CD105+/CD90+/
SC (passage 5) is shown. Cells were fixed in 4% PFA, stained with
nd FITC-conjugated secondary antibodies (green) and processed
system. Nuclei were stained with TO-PRO-3 (red) (magnification
GM130 (Golgi apparatus protein) in ASC. Immunofluorescence
ed in 4% PFA, stained with a primary antibody against CD105,
r Alexa Fluor 555 nm-conjugated secondary antibodies (red) as
) (magnification 1000×). The stained ASC were processed for
m. (C) Characterization of ASC using multi-parameter detection
ow cytometer. FACS histograms of passage 5 ASC simultaneously
Histograms are representative of 3 independent flow cytometry
body staining. (D) Enrichment of DLK1(PREF1) expressing cells
assage 6. (Upper panel) 50,000 cells from each fraction (SVF,
ing using a BD FACS CantoII™ flow cytometer. The percentage of
ent flow cytometry analyses were performed for each fraction.
cells in the SVF and early passage ASC. Cells were fixed in 4%
-conjugated secondary antibodies (green). Nuclei were stained
croscopy using a confocal laser-scanning system (magnification
itive cells a total of 300 cells were analyzed. (E) CD90 and CD31
solated and qRT-PCR analysis performed using specific primers
A binding protein (TBP) and induction calculated based on ASC
F values. Three independent qRT-PCR analyses were performed.
lls were isolated and qRT-PCR analysis performed using specific
binding protein (TBP) and induction calculated based on ASC
F values. Three independent qRT-PCR analyses were performed.
40 MC. Mitterberger et al.functions as negative regulator of adipogenic differentiation in
these cells.
The ASC could differentiate into adipocytes, osteoblasts
and chondrocytes in in vitro assays. The absence of the cell
surface marker F4/80, VWF, and FSP1 in the ASC population
ruled out the presence of macrophages, endothelial cells and
fibroblasts. The FABP4− immunophenotype of the ASC dem-
onstrated the absence of cells already committed to the
adipogenic lineage. Subcutaneous fat has been established as
a source of cultured, relatively homogeneous ASC and ASCfractions are used as defined cell population in clinical studies
(Gimble et al., 2011). Although specific pattern of cellular
surface markers were assigned to human ASC (Maumus et al.,
2008; Mitchell et al., 2006; Schaffler and Buchler, 2007;
Sengenes et al., 2005, 2007), some debate over the criteria
defining a human ASC remains and a consensus on minimal
obligatory criteria for ASC has not yet been defined. In keeping
with the immunophenotype defined by the International
Society for Cell Therapy for mesenchymal stromal cells (MSC)
(Dominici et al., 2006), the vast majority of our ASC robustly
Figure 3 The knockdown of DLK1(PREF1) enhances adipogenesis in human ASC. ASC were infected with two different lentivirus
constructs expressing shRNA against DLK1(PREF1), sh#2 and sh#3, and a mock construct (sh#Control) as a control. (A) The
DLK1(PREF1) knockdown was analyzed by qRT-PCR. Normalization was calculated relative to the mock construct. The data are
presented as the mean±SD of 3 measurements, (**) p≤0.01; (***) p≤0.001. (B) The efficiency of the DLK1(PREF1) protein knockdown
was measured by Western blot analysis. ASC infected with the DLK1(PREF1) overexpression vector, pLentiDLK1(PREF1), served as
positive control. In lane pLentiPREF1 1/10 only 10% of the input from lane pLentiPREF1 was loaded. β-Actin served as loading control.
(C) The knockdown of DLK1(PREF1) enhances adipogenesis in ASC. ASC were infected with lentivirus constructs expressing shRNA
against DLK1(PREF1) (sh#2 and sh#3) or a mock construct (sh#Control) as indicated, and adipogenesis was induced by adding hormone
cocktail. The mRNA levels of the adipogenic regulator PPARγ2, and of the adipogenic differentiation marker FABP-4 were determined
by qRT-PCR analysis at day 3 of adipogenesis. The data are presented as the mean±SD of 3 measurements, (*) p≤0.05; (***) p≤0.001.
41DLK1(PREF1) negatively regulates adipogenesis in CD105+/CD90+/CD34+/CD31− adipose progenitorsexpressed the MSC markers CD90 and CD105 (Gimble and
Guilak, 2003) and were negative for the endothelial cell
marker CD31 (Gimble and Guilak, 2003; Invernici et al., 2005).
CD34, a transmembrane glycoprotein, is known as amarker for
human hematopoietic (Civin et al., 1984) and endothelial
(Asahara et al., 1997) progenitors. In contrast to MSC
(Pittenger et al., 1999) our ASC stained strongly positive for
CD34. This result is in keeping with previous studies from otherFigure 2 Differentiation of ASC. ASC were freshly isolated, grow
results for ASC from four different donors are shown. (A) Immunoflu
0 and day 14 of adipogenesis. Indicated proteins were stained with
conjugated secondary antibodies (green). Nuclei were stained with T
mRNA levels at day 0 and day 6 of adipogenesis. RNA samples of ASC a
analysis performed using specific primers against DLK1(PREF1) and FA
(TBP) and induction calculated based on ASC values which were set to
parameter. (C) DLK1(PREF1) and FABP4 protein levels in ASC at day 0 a
and analyzed by western blotting using antibodies against DLK1(PREF
PPARγ2 (D), C/EBPα (E), adiponectin (F) and leptin (G) mRNA expressi
isolated at the indicated days of differentiation and relative gene ex
analyses were performed for each parameter. (H) ASC were in vitro d
Adipocytes were stained with Oil RedO, chondrocytes with Alcian Bl
conditions changed the morphology of ASC and lineage specific staininresearch groups (De Francesco et al., 2009; Maumus et al.,
2011; McIntosh et al., 2006; Sengenes et al., 2005, 2007;
Zimmerlin et al., 2010). In our ASC CD34 was at peak after
21 days of cultivation at passage 5 and expression remained
stable even after passaging the ASC for 82 days until passage
15. The stable expression of CD34 in later passages is in contrast
to a previous study showing the loss of CD34 at early ASC
passages (Mitchell et al., 2006). However, in that study the ASCn until passage 5 and used for differentiation. Representative
orescence analysis of proliferating and density-arrest ASC at day
primary antibodies against DLK1(PREF1) and FABP4 and FITC-
O-PRO-3 (red) (magnification 400×). (B) DLK1(PREF1) and FABP4
nd control cells were isolated at the indicated days and qRT-PCR
BP4. Expression results were normalized to TATA binding protein
1. Three independent qRT-PCR analyses were performed for each
nd day 6 of adipogenesis. ASC lysates were separated by SDS-PAGE
1) and FABP4. β-actin served as input control. (D–G) Induction of
on during adipogenesis. Differentiation was induced in ASC, mRNA
pression was analyzed by qRT-PCR. Three independent qRT-PCR
ifferentiated into three mesenchymal cell types each for 20 days.
ue and osteoblasts with Alizarin Red-S. All three differentiation
g was found to be positive for each resulting cell type.
42 MC. Mitterberger et al.were cultivated in 10% FBS. The employment of growthmedium
with 2.5% FBS in our study could account for these differences.
It is known that long-term cultivation of cells in high
concentration of FBS leads to changes in the proliferation and
differentiation phenotype induced by mitogenic growth fac-
tors, survival factors and differentiation controlling signals
(Parker et al., 2007; Strehl et al., 2002). This leads to changes in
cell specific markers as well as in the terminal differentiation
capacity (Skurk et al., 2007). Similar to our results a recent
study by Maumus et al. (2011) demonstrated the maintenance
of the CD34 cell surface marker in ASC cultured in 2% FBS and
the loss of CD34 in 10% FBS. Thus our and other studies (Maumus
et al., 2011; McIntosh et al., 2006; Sengenes et al., 2005, 2007;
Zimmerlin et al., 2010) strongly suggest that ASC belong to an
adipose tissue-SVF-derived cell type displaying a CD34+
immunophenotype.
The CD34+/CD31−/CD90+ immunophenotype of our ASC
population matches with stromal cells showing a high adipo-
genic potential. These cells are predominantly detected in the
outer adventitial ring of vessels and in close proximity to
capillaries in adipose tissue in situ (Maumus et al., 2011;
Zimmerlin et al., 2010), which may be major localizations of
ASC in vivo. Another MSC marker endoglin/CD105 (Dominici et
al., 2006), an accessory receptor for TGFβ (Lebrin et al., 2004),
was not analyzed in the study by Zimmerlin et al. (2010). In
accordance with previous studies (Crisan et al., 2008; Schaffler
and Buchler, 2007) CD105was highly expressed in our passage 5
ASC. Some studies found increasing expression of CD105 during
early passaging of ASC in growthmediumwith 10% FBS (Mitchell
et al., 2006). Similarly, human BM MSC show higher levels of
stromal markers, including CD105, in later stages of culture
(Pittenger et al., 1999). Conflicting results came from one
study using fluorescent activating cell sorter (FACS) analyses
showing that the major source of cells in the SVF capable of in
vitro adipogenesis was the CD105−/CD34+/CD31− fraction
(Sengenes et al., 2005). Another group, however, demonstrat-
ed that a CD34+/CD90+/CD105+ ASC fraction isolated from the
SVF by FACS was capable of undergoing endothelial as well as
adipose differentiation (De Francesco et al., 2009), but the
standard “tube” assay (done with Matrigel) was not performed
in this study. In addition, the cells were not clonal, and bona
fide endothelial cells may have been present. Our indirect
immunofluorescence experiments based on confocal micros-
copy, allowing visualization of intracellular structures, dem-
onstrated that CD105 was predominantly localized in the
transport compartments of the ASC and only in a minor amount
in the outer membrane. There might be differences in the
detectability of intracellular CD105 between studies depen-
dent on the methods used for cell permeabilizing, fixing and
antigen detection. Nevertheless, in the present study we
showed that CD105 was highly expressed in our passage 5 ASC,
as demonstrated by FACS and by indirect immunofluorescence
experiments based on confocal microscopy.
We analyzed whether DLK1(PREF1), that was firstly identi-
fied as a putative marker for murine preadipocytes (Smas and
Sul, 1993), could be used as additional marker to characterize
human ASC. We found that DLK1(PREF1) is highly expressed in
human ASC. The DLK1(PREF1) protein levels were similar in
human ASC proliferating in PM4 medium and in density-
arrested G0/G1-phase ASC. In the course of adipogenic
differentiation the DLK1(PREF1) protein level declined.
DLK1(PREF1) was almost undetectable in adipocytes 14 daysafter the induction of adipocyte differentiation. Thus
DLK1(PREF1) is expressed in proliferating ASC, in density-
arrested ASC, and most likely at early stages of adipogenic
differentiation but completely downregulated in human
adipocytes. During adipogenic differentiation of MEFs
(mouse embryonic fibroblasts) the DLK1(PREF1) protein
levels are relatively low in density arrest before differentia-
tion, transiently increased at days 1 and 2, and then decreased
and were undetectable at day 5 after conversion into
adipocytes (Wang and Sul, 2009). Similar in adipogenesis of
the preadipocyte cell line NIH 3 T3 L1 the DLK1(PREF1) protein
levels are low in density arrest before differentiation and
transiently increase until day 2–3 (Garces et al., 1999). When
these cells cease clonal expansion and enter terminal
adipogenic differentiation (Farmer, 2006), the DLK1(PREF1)
protein levels decrease but membranous forms of
DLK1(PREF1) are detectable until day 5 (Garces et al., 1999).
Thus certain forms of DLK1(PREF1) protein are still present at
early stages of terminal adipogenic differentiation and may
contribute to adipocyte differentiation (Garces et al., 1999).
DLK1(PREF1) has been identified as a negative regulator of
adipocyte differentiation in mouse preadipocytes (Smas and
Sul, 1993). Moreover, in its active form, DLK1(PREF1) was
shown to function in an autocrine and paracrine manner as
soluble factor to inhibit differentiation of murine multipotent
MSC into adipocytes, osteoblasts and chondrocytes (Wang and
Sul, 2009; Wang et al., 2010). This suggests that DLK1(PREF1)
has a general role in keeping mouse precursor cells in an
undifferentiated state. In the present study we found that
DLK1(PREF1) functions as negative regulator of adipogenesis
in human ASC. Previous studies have identified DLK1(PREF1) as
regulator of differentiation in human BM MSC (Abdallah et al.,
2004; Jing et al., 2009) and CB MSC (Kluth et al., 2010).
DLK1(PREF1) was used as a marker to distinguish human
unrestricted somatic stem cells and CB MSC (Kluth et al.,
2010). Moreover, DLK1(PREF1) was employed as surface
marker for the isolation and differentiation of chondrogenic
cells derived from human embryonic stem cells (Harkness et
al., 2009). DLK1(PREF1) is also involved in additional differen-
tiation processes in rodent cells, including haematopoiesis
(Moore et al., 1997), pancreatic islet cell differentiation
(Carlsson et al., 1997), Schwann cell differentiation
(Costaglioli et al., 2001), hepatic cell differentiation
(Tanimizu et al., 2004), and differentiation of muscle satellite
cells. Moreover, DLK1(PREF1) is expressed in thymocytes and
neuroblastoma cells [reviewed in Sul, 2009]. Thus DLK1(PREF1)
should be used in combination with additional markers to
distinguish ASC from MSC and other cell types, especially in
combination with the CD34+ and CD31− immunophenotype, as
considered earlier (Gesta et al., 2007).
Studies in mice suggest that the age, depot site and sex of
the donor can influence the features and functionality of the
derived ASC (Cartwright et al., 2010; Gesta et al., 2006; Majka
et al., 2010). Clinical studies found a correlation between donor
age and differentiation capacity of the given ASC (Madonna et
al., 2011; Schipper et al., 2008; Zhu et al., 2009). In humans
also an influence of the BMI (van Harmelen et al., 2003) and fat
depot origin (Tchkonia et al., 2002, 2007) on ASC features was
shown. In the present study, we isolated ASC from subcutane-
ous adipose tissue pads of four different women with an age
between 30 and 47 years and a BMI between 22 and 27 kg/m2.
No differences in the analyzed cell surface marker patterns
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depots of the different donors. Moreover, all ASC populations
had a high capacity to differentiate into adipocytes in vitro, as
demonstrated by the formation of high levels of four terminal
adipogenic differentiation products, FABP4, adiponectin, leptin
and triglycerides. This suggests that the relatively small
differences in age and BMI between our four donors did not
account for major differences in these ASC features. We
detected however differences in the strength of the adipogenic
maturation at the level of single ASC isolated from the same
depot. This was reflected by the difference in the quantity and
size of lipid droplets formed 20 days after the induction of
adipogenesis (Fig. 2H, compare white and yellow arrows).
These findings are in keeping with the differences in the single
cell FABP4 protein level (Fig. 2A, compare white and yellow
arrows). These data suggest that there may be heterogeneity
regarding the adipogenic capacity of ASC within the same
depots. Almost all passage 5 ASC stained strongly positive for
the marker composition DLK1(PREF1)+/CD105+/CD90+/CD34+/
CD31−/FABP4−. However, this marker combination cannot
distinguish ASC with high or low adipogenic capacity. Evidence
for differences between ASC populations cloned from a single
human subcutaneous fat depot regarding the differentiation
capacity was previously shown (Kirkland et al., 1993; Tchkonia
et al., 2005; Zimmerlin et al., 2010). Common observations in
our study were islets of strongly differentiated ASC surrounded
by areas of weaker differentiated ASC. This could, for example,
result from differences in the autocrine/paracrine micromilieu
caused by a different cell density. Such findings could mirror
the existence of different subtypes of ASC in subcutaneous fat
depots in vivo, as discussed previously (Gesta et al., 2007).
More studies are necessary to better understand these
observations.
Material and methods
Subjects
Subcutaneous adipose tissue pads (~100 g wet weight) were
obtained by incision from four women undergoing elective
plastic abdominal surgery (Mitterberger et al., 2010, 2011).
The age of the donors was between 30 and 47 years. The body
mass index of the subjects was between 22 and 27 kg/m2. All
participants gave their informed written consent, and the
protocol was approved by the ethical committee of Innsbruck
Medical University, Austria.
Isolation of human adipose-derived stem cells
The adipose precursor cells were isolated essentially as des-
cribed (Hauner et al., 1989; Rodriguez et al., 2004). Immedi-
ately after surgery adipose tissue biopsies were transferred into
sterile serum-free ASC medium (DMEM/F-12 medium (1:1) with
HEPES and L-glutamine (Gibco, Vienna, Austria), supplemented
with 33 μM biotin, 17 μM pantothenate and 12.5 μg/ml genta-
micin and kept at 4 °C for 1–3 h before sterile processing in a
laminar flow sterile work bench class II. After rinsing with PBS
fibrous material and blood vessels were dissected. The tissue
was cut into pieces (~1–2 mg) and digested in digestion buffer
(PBS containing 200 U/ml collagenase (CLS Type I, Worthington
Biochemical Corp., Lakewood, NJ) and 2% w/v BSA) understirring for 60 min at 37 °C and 450 rpm; 1 mg adipose tissue/
3 ml digestion buffer. The dispersed tissue was centrifuged for
10 min at 200 RCF. The floating adipocytes were aspirated and
the sedimented stromal-vascular fraction (SVF) was suspended
in erythrocyte lysis buffer (0.155 M NH4CI, 5.7 mM K2HPO4,
0.1 mM EDTA, pH 7.3) and incubated for 10 min at room
temperature. To remove tissue debris the cell suspension was
filtered through a nylonmesh (pore size 100 μm). After another
centrifugation step (10 min at 200 RCF) the pelletized SVF was
suspended in ASC medium supplemented with 10% FBS (Gibco,
Vienna, Austria), and filtered through a 35 μmmesh to remove
residual cell aggregates. The pelletized SVF was composed of
single cells. Aliquots of cells were inoculated at a density of
70,000/cm2 into 6-well plates. After 16 h of cell attachment,
cells were washed with ASC medium to remove non-adhering
material, mainly white blood cells and cell debris. Thereafter
the almost confluent cells were maintained for 6 days in ASC
medium without FBS. The medium was changed every second
day. This led to the elimination of all non-adherent cells. The
remaining cell population was referred to as the adipose-
derived stromal cell (ASC) fraction which was used for further
studies. This cell population contains an enriched population of
adipose stem/progenitor cells although most likely not all of
the cells are stem cells, as defined by rigorous criteria.
Cell culture
The ASC were expanded essentially as described (Skurk et
al., 2007). Briefly the cells were washed with PBS and
trypsinized using 0.5% trypsin-EDTA 1x (Gibco, Vienna,
Austria). Trypsin was removed by centrifugation at 300 RCF
for 5 min and the cells seeded in a density of 5000 cells/cm2
in ASC medium plus 10% FBS and maintained at 37 °C with 5%
CO2. 16 h later the medium was replaced by PM4 medium (ASC
medium containing 2.5% FBS, 10 ng/ml EGF, 1 ng/ml bFGF,
500 ng/ml insulin (Skurk et al., 2007)). ASC were passaged at a
ratio of 1:2, medium was changed every third day and the cells
were grown to 70% confluence before splitting. Population
doublings (PDL) were calculated using the following equation: 1
PDL=Log10(N/N0)×3.33 (N = number of cells at the end of a
passage, N0 = number of cells thatwere seeded at the beginning
of a passage). For storage cells were pelleted as described
above, diluted in cryomedium (DMEM/F-12 medium (1:1) (1x)
with HEPES and L-glutamine (Gibco, Vienna, Austria), with 20%
FBS and 7.5% DMSO), at a density of 106 cells/ml, slowly brought
to −80 °C and then stored in frozen nitrogen. After thawing
cryomedium was immediately removed by centrifugation.
Adipogenic differentiation
For the induction of adipogenesis the ASC were seeded at a
density of 10,000 cells/cm2 and grown till confluence for
6 days in PM4 medium. After a resting period of 48 h in ASC
medium adipogenesis was induced using differentiation medi-
um, composed of 0.2 μM insulin (Roche, Vienna, Austria),
0.5 mM IBMX, 0.25 μM dexamethasone, 2.5% FBS, and 10 μg/ml
transferrin (Sigma Vienna, Austria) in ASC medium. After day 3
of differentiation the medium was changed and the cells were
cultivated in differentiation medium without IBMX. For
visualization of lipid droplets cells were fixed with 4%
paraformaldehyde in PBS for 1 h and stained with 0,3% OilRedO
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Final washing was carried out twice with distilled water.
Osteogenic differentiation
For induction of osteogenesis ASC were seeded at a density
of 20,000 cells/cm2 in ACS medium plus 10% FBS. After 16 h
medium was replaced by osteogenic differentiation medium
(STEMPRO Osteocyte/Chondrocyte Differentiation Basal Me-
dium combined with STEMPRO Osteogenesis Supplement
(Gibco, Vienna, Asutria)) and replaced every second day.
After 21 days osteoblasts are fixed with 4% paraformalde-
hyde in PBS for 30 min, washed with PBS and stained with 2%
Alizarin-Red-S (Sigma, Vienna Austria) for 20 min. Final washing
procedure was carried out two times with PBS pH 4.0.
Chondrogenic differentiation
The ASC were seeded in 5 separate 5 μl droplets of ASCmedium
plus 10% FBS, each containing 16,000 cells per 9.6 cm2 well.
After 2 h each well was carefully filled with 2 ml of STEMPRO
Osteocyte/Chondrocyte Differentiation Basal Medium com-
bined with STEMPRO Chondrogenesis Supplement (Gibco,
Vienna, Austria). Medium was replaced every second day.
After 21 days chondrocytes were fixed with 4% paraformalde-
hyde (Sigma) in PBS for 30 min, washed with PBS and stained
with 1% Alcian-Blue 8GX (Molekula, Taufkirchen, Germany) in
0.1 N HCl for 30 min. Final washing was done three times with
0.1 N HCl and two times with distilled water.
Cultivation of human foreskin fibroblasts, HUVEC,
and PBMC
Human foreskin fibroblasts and human umbilical vein endo-
thelial cells (HUVEC) were isolated and cultivated essentially
as described (Wagner et al., 2001). PBMCs were prepared and
cultivated as described (Saurwein-Teissl et al., 1998).
Quantitative RT-PCR
Total RNA was isolated with the RNeasy Micro Kit (Qiagen,
Hilden, Germany), and cDNA synthesis was performed with
the First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Rot,
Germany). Quantitative expression analysis was performed
using the LightCycler® 480 Real-Time PCR System (Roche,
Vienna, Austria). ThemRNA quantification was performed using
β-actin or TATA binding protein (TBP) for normalization.
Primers: The sequences, genbank accession numbers, and the
base numbers of the primers within the sequence are indicated
in Table 1.
Immuofluorescence experiments
Immunofluorescence experimentswere conducted as described
(Mannhardt et al., 2000). Briefly, cells were fixed with 4% (w/v)
PFA/1× PBS, permeabilized with 0.1% (w/v) Na-Citrate/0.2%
(v/v) Triton-X-100, blocked with 1× PBS/1%BSA and incubated
for 1 h at 37 °C with primary antibodies in 1× PBS/1%BSA. After
washing in 1×PBS/1%BSA and staining with secondary IgGs
(DAKOCytomation, Hamburg), cells were processed for indirectimmunofluorescence microscopy and viewed using a confocal
laser-scanning system. Antibodies: Goat anti human endoglin/
CD105, C-20, (Santa Cruz, California, # sc-19790), mouse anti
human CD31 (BD Pharmingen, Heidelberg, # 555446), mouse
anti human CD34 (BD Pharmingen, Heidelberg, #555822),
mouse anti human CD90 (BD Pharmingen, Heidelberg,
#555596), rat anti mouse/human F4/80 (Biolegend, San Diego,
#122615), goat anti human FABP4 C-15 (Santa Cruz, California,
# sc-18661), mouse anti human MTS1/FSP1, X9-7 (Santa Cruz,
California #sc-100784), mouse anti human DLK1/PREF1 (R&D,
Minneapolis, #MAB1144), mouse anti human VWF [F8/86]
(Abcam, Cambridge ab855),mouse anti human calnexin, clone
37 (BD Pharmingen, Heidelberg, #610523), mouse anti rat
GM130, clone 35 (BD Pharmingen, Heidelberg, #610822), anti
mouse/rabbit/goat IgG FITC labeled (DAKOCytomation, Ham-
burg), anti mouse/goat IgG Alexa Fluor 555 nm/488 nm
(Invitrogen, Lofer); TO-PRO-3 served as nucleic acid dye
(Invitrogen, Lofer).
Westernblot analysis
Cell lysates were prepared in sample buffer (2% SDS, 6%
glycerine, 0,1 M DTT, 0,5% brom-phenol-blue, 62.5 mM Tris–
HCl pH 6.8), separated by SDS-PAGE and western blot analysis
was performed essentially as described (Jodar et al., 2010).
Antibodies: Mouse anti human βactin, clone AC-15 (Sigma,
Missouri, #A5441), goat anti human FABP4, clone C-15, (Santa
Cruz, California, # sc-18661), rat anti human DLK1 (PREF1)
(AdipoGen, San Diego, # AG-25A-0091), anti mouse IgG HRP
conjugate (Promega, Mannheim #W420B), donkey anti goat
IgG-HRP (Promega, Mannheim #V805A), rabbit anti-rat IgG HRP
(Dako Cytomation, Hamburg, #P0450).
Plasmids/lentiviruses
pMD2.G, psPAX2 and pLKO.1 TRC (sh control vector) (D. Trono
# 12259, D. Trono #12260, Root #10879, Addgene, Cambridge,
USA). The DLK1(PREF1) overexpressing lentivirus, pLen-
tiDLK1(PREF1), was constructed inserting the full length
human DLK1(PREF1) cDNA from pCMV6-AC-DLK1(PREF1),
NM_003836 (SC320741) (Origene, Rockville) into pLenti6/
DEST (Invitrogen, Lofer, Austria) using the Gateway Lentiviral
Cloning System, Invitrogen, Lofer, Austria. The correct
DLK1(PREF1) cDNA sequence in plentiDLK1(PREF1) was veri-
fied by sequencing. DLK1(PREF1) shRNA lentiviruses: sh#2 and
sh#3 (TRCN0000055979 and TRCN0000055980 of the shRNA set
#RHS4533 for NM_003836, Open Biosystems, Vienna).
Retroviral gene expression system
5 different pLKO.1 lentiviral DLK1(PREF1) shRNA vectors for
accession NM_003836 (#RHS4533, Open Biosystems, Vienna)
were used for lentiviral particle production employing the
ViraPowerTM Lentiviral Expression System (Invitrogen,
Lofer, Austria) and a second-generation system provided by
the Trono lab (Addgene, Cambridge, USA). The same
procedure was used to generate virus particles of the
DLK1(PREF1) overexpressing lentivirus pLentiDLK1(PREF1).
The purified viral particles were stored at −80 °C. For viral
infection, 900,000 ASC were seeded in a 75-cm2 bottle, with
8 ml medium, 6 μg/ml polybrene and virus particles at a
Table 1 Primer list: The sequences, genbank accession numbers, and the base numbers of the primers within the sequence are
indicated.
Gene Accession number Direction Sequence Base numbers
βActin NM_001101 Forward AGA AAA TCT GGC ACC ACA CC 332–350
Reverse AGA GGC GTA CAG GGA TAG CA 500–519
AdipoQ NM_004797 Forward CCT GGT GAG AAG GGT GAG AA 268–287
Reverse GTA AAG CGA ATG GGC ATG TT 463–482
C/EBPα NM_004364 Forward GCG GCG ACT TTG ACT ACC 418–435
Reverse GCT TGG CTT CAT CCT CCT C 606–524
CD31 NM_000442 Forward GAG TCC TGC TGA CCC TTC TG 254–273
Reverse ATC TGG TGC TGA GGC TTG AC 412–431
CD90 NM_006288 Forward GAA CCA ACT TCA CCA GCA AA 286–305
Reverse ATG CCC TCA CAC TTG ACC A 436–454
PU.1/F4/80 NM_001080547 Forward CAC CCC ATC CCA GTC TTG 531–548
Reverse TCT TCT TGC TGC CTG TCT CC 712–731
FABP4 NM_001442 Forward CAG TGT GAA TGG GGA TGT GA 176–195
Reverse CGT GGA AGT GAC GCC TTT 408–425
FSP1/S100A4 NM_002961 Forward GGG CAA AGA GGG TGA CAA 129–146
Reverse CTT CCT GGG CTG CTT ATC TG 350–369
Leptin NM_000230 Forward CAC ACG CAG TCA GTC TCC TC 196–215
Reverse AGG TTC TCC AGG TCG TTG G 350–368
PPARγ2 NM_015869 Forward ATG GGT GAA ACT CTG GGA GA 92–111
Reverse TGG AAT GTC TTC GTA ATG TGG A 316–337
PREF1 NM_003836 Forward TGA CCA GTG CGT GAC CTC T 315–333
Reverse GGC AGT CCT TTC CCG AAGT A 508–526
TBP NM_003194 Forward ATG ACC CCC ATC ACT CCT G 668–686
Reverse GCA CAC CAT TTT CCC AGA AC 876–895
VWF NM_000552 Forward CGC ATC CAG CAT ACA GTG AC 1691–1710
Reverse GAG GGG GTA AGG AAG TCG TC 1847–1866
45DLK1(PREF1) negatively regulates adipogenesis in CD105+/CD90+/CD34+/CD31− adipose progenitorsmultiplicity of infection (MOI) of 1:4. After 24 h, the medium
was changed, and the cells were grown for another 48 h before
they were trypsinized and seeded at 10,000 cells/cm2 for
subsequent differentiation. The efficiency of the DLK1(PREF1)
knockdown was measured by qRT-PCR and Western blot
analysis 4 days after infection or later. The most efficient
knockdown clones for DLK1(PREF1) (sh#2 and sh#3) which were
identified by qRT-PCR and Western blotting were used for
further experiments.
Flow cytometry analysis
SVF and trypsinized early passage ASC, 250,000 cells per
sample, were simultaneously fixed and permeabilized using
BD Cytofix/Cytoperm™ solution to prepare the cells for
intracellular and surface marker staining. The cells were
subjected to immunofluorescence staining using a panel of
directly conjugatedmousemonoclonal antibodies: CD31-FITC-
A (WM59) #557508, CD34-PE-Cy7A (581) #560710, CD90-PE-A
(5E10) #555596, CD105-PerCP-Cy5-5-A (266) #560819 (BD
Pharmingen, Heidelberg). For DLK1/PREF1 immunofluores-
cence staining a rat monoclonal anti human DLK1/PREF1
antibody (AG-25A-0091, Adipogen, San Diego) was used in
combination with an anti-rat-APC-A antibody (BD Pharmingen,
Heidelberg, #551019). The labeled cells were measured using
a FACSCanto II (BD Biosciences) and the data were analyzed
using the FACSDiva software (BD Biosciences).Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2012.04.001.
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